Breast lesion localization devices aid in marking of lesion sites majorly in non-palpable breast lesions and guide in surgical excision of lesions. With the rise in breast cancer awareness, women are adopting preventive screening options that have created a favorable environment for the growth of breast lesion localization solutions. Localization of the lesion becomes necessary in order to guide the efficiency of neo-adjuvant therapies. Emergence of newer technologies such as SAVI SCOUT by Cianna Medical, Inc. engages the market and ascertains lucrative growth.
The study report on breast lesion localization devices comprehends a thorough information on the present market dynamics and movements for the period, 2016-2026. The report provides an exhaustive understanding on the market scenario, ongoing strategies and gives analysis on the future market landscape across the time scale, 2018 to 2026.
The breast lesion localization devices market has been researched and studied based on the products utilized for various breast lesion localization techniques.
Market analysis and forecast evaluations for the aforementioned segments have been incorporated in this study report for the time period 2016-2026 with values in US$ Mn. Additionally, respective CAGRs for each respective segments have also been included for the time scale, 2018-2026, by considering 2017 as the base year.
The current study report also includes qualitative parameters that would assist key players in gauging the current market trends and aid in making strategic initiatives. Market drivers, opportunities and restraints are some of the key factors that have been described in this study. Competitive landscape of the existing dominant players and emerging key players has also been incorporated within this report. Company profiles of each of dominant and emerging players pertaining to their financial information, current market trends and marketed products have been presented. The market leaders profiled in this research Best Medical International Inc., C.R. BARD, Inc., Cianna Medical, Inc., Cook Medical (Cook Group Incorporated), CP Medical, Inc., IsoAid LLC, SOMATEX Medical Technologies GmbH and STERYLAB S.r.l.
Of the aforementioned techniques, wire localization predominates the market owing to its earlier market entry and steady growing demand. During the forecast period, this segment may face a setback due to drawbacks such as displacements from the placed region, patient discomfort and difficulty in placing the wire near the lesion. Radioisotope localization is currently gaining demand, as it requires minimal procedural time and provides efficient results. However, radioisotopes cause side effects and incorrect injection may lead to severe complications. The latest technology of using electromagnetic waves has witnessed a soaring demand in the market owing to its lesser side effects and higher efficiency. For example, SCOUT by Cianna Medical, Inc. uses electromagnetic waves that detects a reflector placed in the target site. Such advancements propels demand in the market thus leading to lucrative growth in the forecast period, 2018-2026.
Breast cancer is the most frequently occurring form of cancer amongst women worldwide. For the purpose of this study, geographies namely North America, Europe, Asia Pacific, Latin America, and Middle East & Africa have been analyzed. It is found that white women are more prone to breast cancer followed by black and non-Hispanic women. Asian women show comparatively lesser incidence rates of breast cancer. Considering the above-mentioned factors, North America predominates the breast lesion localization devices market. Additionally, existence of well-developed healthcare infrastructure, special reimbursement policies for breast cancer biopsies and presence of manufacturers such as Best Medical International, Inc., C.R. BARD, Inc., and others have contributed to the overall growth of breast lesion localization products market in this region. Europe also holds a dominant position in this market considering breast cancer being the most common form of cancer in this region. According to Cancer Research UK, incidence rate of breast cancer are expected to rise by 2% in the U.K. between the period 2014 to 2035, which would account to 210/100,000 female cases by 2035. The rising incidence rates propels the further growth of breast lesion localization products market in the forecast period, 2018-2026.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Breast Lesion Localization Devices market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Technique
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
